Jiangsu Apon Medical Technology Co., Ltd. (300753.SZ)
CNY 19.51
(1.19%)
CNY 19.51
(1.19%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -124.47 Million CNY | 31.18% |
| 2022 | -180.87 Million CNY | 22.97% |
| 2021 | -234.8 Million CNY | 38.98% |
| 2020 | -384.83 Million CNY | 8.5% |
| 2019 | -420.59 Million CNY | 3.56% |
| 2018 | -436.13 Million CNY | -156.82% |
| 2017 | -169.82 Million CNY | -19.83% |
| 2016 | -141.71 Million CNY | -99.38% |
| 2015 | -71.07 Million CNY | -675.56% |
| 2014 | -9.16 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -18.45 Million CNY | -147.96% |
| 2024 Q1 | 38.48 Million CNY | 130.92% |
| 2024 Q3 | -13.07 Million CNY | 161.84% |
| 2023 Q2 | -42.13 Million CNY | -274.88% |
| 2023 Q4 | -124.47 Million CNY | -258.31% |
| 2023 Q3 | -34.74 Million CNY | 17.55% |
| 2023 FY | -124.47 Million CNY | 31.18% |
| 2023 Q1 | 24.09 Million CNY | 113.32% |
| 2022 Q2 | -121.16 Million CNY | -7.35% |
| 2022 FY | -180.87 Million CNY | 22.97% |
| 2022 Q4 | -180.87 Million CNY | -113.47% |
| 2022 Q3 | -84.73 Million CNY | 30.07% |
| 2022 Q1 | -112.86 Million CNY | 51.93% |
| 2021 FY | -234.8 Million CNY | 38.98% |
| 2021 Q4 | -234.8 Million CNY | -43.67% |
| 2021 Q3 | -163.44 Million CNY | 24.59% |
| 2021 Q2 | -216.72 Million CNY | 18.65% |
| 2021 Q1 | -266.43 Million CNY | 30.77% |
| 2020 Q1 | -368.43 Million CNY | 12.4% |
| 2020 Q3 | -227.56 Million CNY | -2.01% |
| 2020 Q4 | -384.83 Million CNY | -69.1% |
| 2020 FY | -384.83 Million CNY | 8.5% |
| 2020 Q2 | -223.07 Million CNY | 39.45% |
| 2019 Q4 | -420.59 Million CNY | -871.22% |
| 2019 FY | -420.59 Million CNY | 3.56% |
| 2019 Q3 | -43.3 Million CNY | 40.36% |
| 2019 Q2 | -72.61 Million CNY | -4.37% |
| 2019 Q1 | -69.56 Million CNY | 84.05% |
| 2018 Q1 | 169.82 Million CNY | 200.0% |
| 2018 FY | -436.13 Million CNY | -156.82% |
| 2018 Q4 | -436.13 Million CNY | -175.05% |
| 2018 Q3 | -158.56 Million CNY | 10.01% |
| 2018 Q2 | -176.19 Million CNY | -203.76% |
| 2017 FY | -169.82 Million CNY | -19.83% |
| 2017 Q4 | -169.82 Million CNY | 0.0% |
| 2016 FY | -141.71 Million CNY | -99.38% |
| 2015 FY | -71.07 Million CNY | -675.56% |
| 2014 FY | -9.16 Million CNY | 0.0% |